Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131901) titled 'Irinotecan liposomes (II) in combination with 5-FU/LV and oxaliplatin in locally advanced pancreatic cancer: a prospective, single-arm, multicenter Phase II study' on Sept. 7.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: The First Affiliated Hospital of Sun Yat-sen University
Condition:
Pancreatic tumor
Recruitment Status: Recruiting
Phase: 2
Date of First Enrollment: 2025-10-24
Target Sample Size: Experimental Group:41;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=286329
Published by HT Digital Content Services wit...